Compare Sun Pharma with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs DISHMAN CARBOGEN AMCIS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA DISHMAN CARBOGEN AMCIS SUN PHARMA/
DISHMAN CARBOGEN AMCIS
 
P/E (TTM) x 72.2 -19.5 - View Chart
P/BV x 3.6 0.6 646.2% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 SUN PHARMA   DISHMAN CARBOGEN AMCIS
EQUITY SHARE DATA
    SUN PHARMA
Mar-20
DISHMAN CARBOGEN AMCIS
Mar-21
SUN PHARMA/
DISHMAN CARBOGEN AMCIS
5-Yr Chart
Click to enlarge
High Rs484217 223.4%   
Low Rs31553 594.2%   
Sales per share (Unadj.) Rs136.9122.0 112.2%  
Earnings per share (Unadj.) Rs17.4-10.5 -165.7%  
Cash flow per share (Unadj.) Rs26.09.1 285.5%  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs188.7363.5 51.9%  
Shares outstanding (eoy) m2,399.34156.78 1,530.4%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.91.1 264.1%   
Avg P/E ratio x22.9-12.8 -178.9%  
P/CF ratio (eoy) x15.414.8 103.8%  
Price / Book Value ratio x2.10.4 571.0%  
Dividend payout %22.90-   
Avg Mkt Cap Rs m958,89421,142 4,535.5%   
No. of employees `000NANA-   
Total wages/salary Rs m63,6248,729 728.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m328,37519,120 1,717.4%  
Other income Rs m6,516385 1,694.6%   
Total revenues Rs m334,89119,505 1,717.0%   
Gross profit Rs m67,1352,521 2,663.4%  
Depreciation Rs m20,5283,079 666.6%   
Interest Rs m3,027476 635.9%   
Profit before tax Rs m50,096-650 -7,703.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,2281,001 822.0%   
Profit after tax Rs m41,868-1,651 -2,535.5%  
Gross profit margin %20.413.2 155.1%  
Effective tax rate %16.4-153.9 -10.7%   
Net profit margin %12.8-8.6 -147.6%  
BALANCE SHEET DATA
Current assets Rs m316,54216,626 1,903.8%   
Current liabilities Rs m157,06412,488 1,257.7%   
Net working cap to sales %48.621.6 224.4%  
Current ratio x2.01.3 151.4%  
Inventory Days Days158118 134.1%  
Debtors Days Days1057 1,446.6%  
Net fixed assets Rs m334,23066,517 502.5%   
Share capital Rs m2,399314 765.1%   
"Free" reserves Rs m450,24556,675 794.4%   
Net worth Rs m452,64556,988 794.3%   
Long term debt Rs m20,2895,039 402.6%   
Total assets Rs m650,77283,144 782.7%  
Interest coverage x17.5-0.4 -4,796.0%   
Debt to equity ratio x00.1 50.7%  
Sales to assets ratio x0.50.2 219.4%   
Return on assets %6.9-1.4 -488.1%  
Return on equity %9.2-2.9 -319.2%  
Return on capital %11.2-0.3 -3,999.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m74,2191,554 4,776.9%   
Fx outflow Rs m27,964210 13,297.1%   
Net fx Rs m46,2551,343 3,443.1%   
CASH FLOW
From Operations Rs m65,5485,134 1,276.7%  
From Investments Rs m-25,888-3,808 679.9%  
From Financial Activity Rs m-57,151-110 51,767.6%  
Net Cashflow Rs m-13,8571,216 -1,139.5%  

Share Holding

Indian Promoters % 54.5 59.3 91.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.5 15.3 218.5%  
FIIs % 11.5 6.4 180.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 45.5 40.7 111.9%  
Shareholders   757,366 58,738 1,289.4%  
Pledged promoter(s) holding % 6.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   TTK HEALTHCARE  SANJIVANI PA  NATURAL CAPS  ADVIK LABORS  SMS PHARMA  



Today's Market

Sensex Recovers 640 Points from Day's Low; Dr Reddy's Laboratories & Kotak Mahindra Bank Among Top Nifty Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 31.6% (Quarterly Result Update)

May 28, 2020 | Updated on May 28, 2020

For the quarter ended March 2020, SUN PHARMA has posted a net profit of Rs 5 bn (down 31.6% YoY). Sales on the other hand came in at Rs 82 bn (up 14.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 29.8% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, SUN PHARMA has posted a net profit of Rs 10 bn (down 29.8% YoY). Sales on the other hand came in at Rs 82 bn (up 5.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

More Views on News

Most Popular

RBI Opens a New Market for Investors(Fast Profits Daily)

Jul 16, 2021

You now have a new way to create wealth. Grab it with both hands.

These Are the Best Stocks to Own(Fast Profits Daily)

Jul 22, 2021

Find out what I think are the best kind on stocks to own in the market.

India's Vulture Moment Against China(Fast Profits Daily)

Jul 15, 2021

India has a great opportunity to grab market share from China. Profit from it.

Top 5 Stocks Mutual Funds Bought and Sold in June 2021(Views On News)

Jul 15, 2021

A look at what India's top equity mutual funds bought and sold in June 2021.

Zomato: Worth a Bite?(Profit Hunter)

Jul 15, 2021

Zomato has been a consumer's delight. Can it be an investor's delight too?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Jul 28, 2021 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA 8-QTR ANALYSIS

COMPARE SUN PHARMA WITH

MARKET STATS